Antibacterial agents in infections of the central nervous system.
Publication/Presentation Date
6-1-2000
Abstract
Experimental animal models have provided information applicable to antimicrobial therapy of infections of the central nervous system. The efficacy of an antimicrobial agent in the therapy of bacterial meningitis depends on its ability to penetrate the blood-brain barrier, its activity in purulent cerebrospinal fluid, and a demonstration of rapid bactericidal activity against the offending pathogen. The recent emergence of resistant pathogens is challenging the therapy for bacterial meningitis. Various strategies for treating resistant pathogens have been evaluated in experimental animal models. Encouraging results have led to clinical trials to evaluate the efficacy of newer agents, alone or in combination with standard regimens.
Volume
14
Issue
2
First Page
391
Last Page
408
ISSN
0891-5520
Published In/Presented At
Chowdhury, M. H., & Tunkel, A. R. (2000). Antibacterial agents in infections of the central nervous system. Infectious disease clinics of North America, 14(2), 391–ix. https://doi.org/10.1016/s0891-5520(05)70254-3
Disciplines
Medicine and Health Sciences
PubMedID
10829262
Department(s)
Department of Medicine
Document Type
Article